Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2016 from OUS - Rheumatology Research Group
16 publications found
Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study
Scand J Rheumatol, 45 (4), 299-303
DOI 10.3109/03009742.2015.1126345, PubMed 26854592
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
Am J Hum Genet, 100 (1), 64-74
DOI 10.1016/j.ajhg.2016.11.013, PubMed 28041642
OX40L blockade protects against inflammation-driven fibrosis
Proc Natl Acad Sci U S A, 113 (27), E3901-10
DOI 10.1073/pnas.1523512113, PubMed 27298374
Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility
BMC Med Genet, 17, 24
DOI 10.1186/s12881-016-0285-3, PubMed 27005825
Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
Scand J Immunol, 84 (2), 95-9
DOI 10.1111/sji.12445, PubMed 27135178
Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway
Arthritis Care Res (Hoboken), 69 (2), 278-285
DOI 10.1002/acr.22931, PubMed 27159262
Mixed connective tissue disease
Best Pract Res Clin Rheumatol, 30 (1), 95-111
DOI 10.1016/j.berh.2016.03.002, PubMed 27421219
Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study
Ann Rheum Dis, 76 (1), 159-165
DOI 10.1136/annrheumdis-2016-209522, PubMed 27283334
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Chest, 150 (2), 299-306
DOI 10.1016/j.chest.2016.03.004, PubMed 26997242
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
Liver Int, 37 (3), 458-465
DOI 10.1111/liv.13238, PubMed 27558072
Temporomandibular joint involvement in childhood arthritis: comparison of ultrasonography-assessed capsular width and MRI-assessed synovitis
Dentomaxillofac Radiol, 45 (8), 20160195
DOI 10.1259/dmfr.20160195, PubMed 27383060
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis Rheumatol, 68 (9), 2338-44
DOI 10.1002/art.39730, PubMed 27111665
Endostatin is higher and associated with pulmonary involvement in primary Sjögren's syndrome
Clin Exp Rheumatol, 34 (4), 690-3
PubMed 27214260
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies
RMD Open, 2 (2), e000291
DOI 10.1136/rmdopen-2016-000291, PubMed 27752355
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
J Allergy Clin Immunol, 139 (1), 232-245
DOI 10.1016/j.jaci.2016.05.042, PubMed 27577878
T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity
J Allergy Clin Immunol, 138 (3), 839-851.e8
DOI 10.1016/j.jaci.2016.01.035, PubMed 27056269